Venkat Venkataramanan, PhD, is the founding director and Chief Technology Officer of Lumentra Inc. He obtained his doctoral degree in Physics from the Indian Institute of Science, Bangalore. He then held various research and teaching positions in the UK, India, Portugal and Japan. He is now the Director, Scienctific Operations of the Institute for Optical Sciences at the University of Toronto. He is a Canadian National Advisory Committee member of International Commission on Illumination (CIE). He also serves on the technical committees of ANSI and IOS. Venkataramanan is also an Adjunct Professor in the Department of Electrical and Computer Engineering at Ryerson University in Toronto.
Sridhar (Sri) Krishnan is an Interim Associate Dean for Research and Development in the Faculty of Engineering, Architecture and Science, and a Professor in the Department of Electrical and Computer Engineering at Ryerson University, Toronto. He holds the Canada Research Chair position in Biomedical Signal Analysis. He received a PhD degree in Electrical and Computer Engineering from the University of Calgary, Calgary, Alberta, Canada. Sri Krishnan is a registered Professional Engineer in the Province of Ontario, and the Chair of IEEE Signal Processing Society, Toronto Section and Region 7 (Canada).
Sri Krishnan is a receipient of the 2008 Ontario Research Innovation Award from Biodiscovery Toronto; 2007 Canadian Engineers’ Young Engineer Achievement Award from Engineers’ Canada; 2006 New Pioneers Award in Science and Technology; 2006 South Asian Community Achiever Award; 2006 IEEE Toronto Section Best Chapter Chair Award; 2005 IEEE AESS Best Chapter Chair Award; 2005 IEEE Certificate of Appreciation from Six Societies; Four Best Research Paper Awards co-authored with his graduate students in National and International Conferences; and 2005 FEAS Research Excellence Award.
Sri Adapa is currently the General Manager of the Canadian operations and a Member of the Global Management Committee at Octapharma, the world’s largest privately held bio pharmaceutical company specializing in human protein based treatments for bleeding disorders. He is an experienced business leader with expertise in directing global business strategy, strategic decision making, portfolio management and pharmacoeconomics. Through his previous commercial leadership roles at Abbott, Novartis and Aventis, he has developed global brands and has a deep working knowledge of key global and emerging health care markets. His global outlook has been further shaped through his stays in the US, Canada, Germany, Switzerland and other countries.
Sri has an MBA in global marketing and a Bachelors degree in Pharmacy.